Page last updated: 2024-08-24

valsartan and Endomyocardial Fibrosis

valsartan has been researched along with Endomyocardial Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, S; Aizawa, Y; Hanawa, H; Hayashi, M; Hui, L; Kashimura, T; Kato, K; Kodama, M; Nakazawa, M; Tachikawa, H; Watanabe, K; Yoshida, T1
Amiri, F; Brassard, P; Iglarz, M; Javeshghani, DM; Pu, Q; Schiffrin, EL; Webb, RL1

Other Studies

2 other study(ies) available for valsartan and Endomyocardial Fibrosis

ArticleYear
Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
    Journal of cardiovascular pharmacology, 2003, Volume: 41 Suppl 1

    Topics: Angiotensin Receptor Antagonists; Animals; Autoimmune Diseases; Cardiomyopathies; Endomyocardial Fibrosis; Heart Ventricles; Male; Myocarditis; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan; Ventricular Function

2003
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Journal of hypertension, 2008, Volume: 26, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Endomyocardial Fibrosis; Endothelium, Vascular; Hydralazine; Hypertension; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Tetrazoles; Tyrosine; Valine; Valsartan

2008